Showing results (151-160 of 510) with videos related to

Sort By:
Pageof 51
Human Gene Therapy|September 8, 2011
Human involucrin promoter mediates repression-resistant and compartment-specific LEKTI expressionWei-Li Di, Ekaterina Semenova, Fernando Larcher, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 24, 2007
A potential screening tool for IPEX syndromeMeredith Lee Heltzer, John K Choi, Hans D Ochs, et al.
Revista Medica De Chile|June 7, 2003
[X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case]Cristián Rodríguez, Flavio Carrión, María Angélica Marinovic, et al.
Pediatric Blood & Cancer|April 19, 2008
Familial hemophagocytic lymphohistiocytosis in two brothers with X-linked agammaglobulinemiaKris Ann P Schultz, Joseph P Neglia, Angela R Smith, et al.
The Journal of Experimental Medicine|June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceMaxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2020
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerationsHans-Hartmut Peter, Hans D Ochs, Charlotte Cunningham-Rundles, et al.
Journal of Clinical Immunology|June 10, 2016
Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency DiseasesMark Ballow, Paul J Pinciaro, Timothy Craig, et al.
Blood|January 17, 2004
WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorptionYolanda Calle, Gareth E Jones, Chris Jagger, et al.
Journal of Virology|January 30, 2009
Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapyKatarzyna Karwacz, Sayandip Mukherjee, Luis Apolonia, et al.
Pageof 51